CASE STUDY
Client: Mayne Pharma
Category:
Date:
Overview
Mayne Pharma sought a creative solution to educate women aged 18-35 about the benefits of estrogen, specifically E4, in a way that would boost awareness and engagement. The goal was to create an innovative, engaging platform that would resonate with this demographic.
PROJECT BRIEF
Objectives
- Increase Awareness of Estetrol (E4): Create a platform to educate the audience on the benefits and unique aspects of E4, the newest FDA-approved estrogen for birth control in over 60 years.
- Educate on Estrogen and Hormones: Provide an interactive learning experience that explains the role of estrogen and hormones in birth control and their impact on women’s health.
- Boost Engagement Metrics: Enhance site engagement, track key metrics like page visits, engagement rate, conversion visits, time spent on site, and return visit rates to evaluate the platform’s effectiveness.
Success Metrics
- Increase Awareness of E4 and its Benefits: Through an immersive unbranded experience, Estrogen IQ aimed to boost knowledge about Estetrol and its revolutionary role in birth control products.
- Educational Impact: Focus on educating visitors on the role of estrogen, emphasizing the unique properties of E4 and its benefits in the Nextstellis contraceptive pill.
- Engagement and Interaction: Measured by visits, engagement rate, conversion rates, page views per visit, homepage bounce rate, unique visitors, and return visit rate.
V-UNITE SOLUTION
Estrogen IQ delivered an engaging, unbranded experience to help users understand the benefits of E4:
- Interactive Learning Modules: Users were guided through engaging, visually appealing content that highlighted the role of Estetrol in birth control and its benefits over other types of estrogen.
- Focus on Education: The platform focused on explaining how hormones, specifically estrogen, work within contraceptives, helping to simplify complex medical information for the general public.
- Engagement Through Gamification: Quizzes and interactive exhibits allowed users to test their knowledge about E4, ensuring a more memorable and impactful learning experience.
RESULT
The Estrogen IQ initiative successfully met its objectives, with key outcomes including:
- Increased Awareness of Estetrol (E4): The platform educated thousands of users about the benefits of E4 and its role in Nextstellis, making it a trusted source of information about this newly FDA-approved estrogen.
- High Engagement Rates: The site saw strong engagement metrics, including higher conversion rates, longer time spent on site, and a notable number of return visits, indicating a successful educational experience.
- Improved Knowledge Retention: Visitors left the experience with a greater understanding of how E4 works, with the platform’s quizzes and interactive features contributing to improved retention of information
Bring your event into a world full of virtual possibilities.
ENGAGE. INTERACT. GROW.